| metabolic encephalopathy | Encephalopathy characterised by memory loss, vertigo, and generalised weakness, due to metabolic brain disease including hypoxia, ischemia, hypoglycaemia, or secondary to other organ failure such as liver or kidney. (05 Mar 2000) |
|---|---|
| metabolic equivalent | The oxygen cost of energy expenditure measured at supine rest (1 MET = 3.5 ml O2 per kg of body weight per minute); multiples of MET are used to estimate the oxygen cost of activity, e.g., 3 to 5 METs for light work; more than 9 METs for heavy work. (05 Mar 2000) |
| metabolic indican | 1. <chemistry> A glucoside obtained from woad (indigo plant) and other plants, as a yellow or light brown sirup. It has a nauseous bitter taste, a decomposes or drying. By the action of acids, ferments, etc, it breaks down into sugar and indigo. It is the source of natural indigo. 2. <physiology> An indigo-forming substance, found in urine, and other animal fluids, and convertible into red and blue indigo (urrhodin and uroglaucin). Chemically, it is indoxyl sulphate of potash, C8H6NSO4K, and is derived from the indol formed in the alimentary canal. Synonym: uroxanthin. See: Indigo. Source: Websters Dictionary (01 Mar 1998) |
| metabolic mucinosis | Diffuse or pretibial myxoedema, lichen myxoedematosus, gargoylism, secondary mucinosis, degeneration in tumours, localised mucinosis, follicular, papular, plaque-like, focal, and myxoid or synovial cyst. Origin: mucin + G. -osis, condition (05 Mar 2000) |
| metabolic pool | The quantity of a given chemical compound or group of related compounds participating in metabolic reactions; may constitute only a portion of the total bodily content of such compounds. (05 Mar 2000) |
| compensated metabolic alkalosis | The retention of acid, primarily carbon dioxide by the lung and acid ions by the renal tubules, to reduce the effect on the pH of the blood of excess alkali produced by ingestion or metabolism of alkali-producing substances. (05 Mar 2000) |
| skin diseases, metabolic | Diseases of the skin associated with underlying metabolic disorders. (12 Dec 1998) |
| steroid metabolic clearance rate | A measure of the rate of metabolism of a given steroid within the body, usually expressed as liters of body fluid that contain the amount of steroid metabolised per day. (05 Mar 2000) |
| nutritional and metabolic diseases | A collective term for nutritional disorders (result of poor assimilation or utilization of food) and metabolic disorders (result of poor metabolism or inherited enzyme abnormality). (12 Dec 1998) |
| macrorestriction map | <molecular biology> Map depicting the order of and distance between sites at which restriction enzymes cleave chromosomes. (09 Oct 1997) |
| map | 1. A representation of the surface of the earth, or of some portion of it, showing the relative position of the parts represented; usually on a flat surface. Also, such a representation of the celestial sphere, or of some part of it. There are five principal kinds of projection used in making maps: the orthographic, the stereographic, the globuar, the conical, and the cylindrical, or Mercator's projection. See Projection. 2. Anything which represents graphically a succession of events, states, or acts; as, an historical map. "Thus is his cheek the map of days outworn. <botany>" (Shak) Map lichen, a lichen (Lecidea geographica) growing on stones in curious maplike figures. Origin: From F. Mappe, in mappemonde map of the world, fr. L. Mappa napkin, signal cloth; a Punic word. Cf. Apron, Napkin, Nappe. Source: Websters Dictionary (01 Mar 1998) |
| map, contig | A map depicting the relative order of a linked library of small overlapping clones representing a complete chromosome segment. (12 Dec 1998) |
| map distance | The degree of separation of two loci on a linkage map, measured in morgans or centimorgans. (05 Mar 2000) |
| map-dot-fingerprint dystrophy | Fingerprint dystrophy accompanied by map-like patterns and microcystic epithelial inclusions. (05 Mar 2000) |
| MAP kinase | Mitogen activated protein kinases. (ERKs: externally regulated kinases) Serine threonine kinases that are activated when quiescent cells are treated with mitogens and therefore potentially transmit signal for entry into cell cycle. One target is trancription factor p62TCF. MAP kinase itself can be phosphorylated by MAP kinase kinase and this may in turn be controlled by RAF 1. Confusingly, do phosphorylate microtubule-associated proteins. (18 Nov 1997) |